GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Scaled Net Operating Assets

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Scaled Net Operating Assets : 0.65 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Malaysian Genomics Resource Centre Bhd's operating assets for the quarter that ended in Mar. 2024 was RM24.25 Mil. Malaysian Genomics Resource Centre Bhd's operating liabilities for the quarter that ended in Mar. 2024 was RM2.21 Mil. Malaysian Genomics Resource Centre Bhd's Total Assets for the quarter that ended in Sep. 2023 was RM33.72 Mil. Therefore, Malaysian Genomics Resource Centre Bhd's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.65.


Malaysian Genomics Resource Centre Bhd Scaled Net Operating Assets Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Scaled Net Operating Assets Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 0.64 0.54 - -

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.95 0.82 0.66 0.65

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets falls into.



Malaysian Genomics Resource Centre Bhd Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2021 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2021 )
=(Operating Assets (A: Jun. 2021 )-Operating Liabilities (A: Jun. 2021 ))/Total Assets (A: Jun. 2020 )
=(11.474-3.203)/0
=N/A

where

Operating Assets(A: Jun. 2021 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=22.783 - 11.309
=11.474

Operating Liabilities(A: Jun. 2021 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.853 - 1.302 - 0.348
=3.203

Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Sep. 2023 )
=(24.249-2.212)/33.716
=0.65

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=24.685 - 0.436
=24.249

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.094 - 1.516 - 0.366
=2.212

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines